Skip to content
Anya Snary staff photo

Anya Snary

Lecturer

School of Social Sciences

Role

Dr. Anya Snary is a molecular and cellular neurobiologist who is currently a Lecturer in Health Biosciences at Nottingham Trent University

Anya currently works at Nottingham Trent University where she is responsible for the module leadership of 'Applied Anatomy and Physiology' for Nursing Associates. Alongside this, Anya teaches a range of Anatomy, Physiology, Pharmacology, Neuropharmacology and Pathophysiology across BSc and MSc courses to students in the Institute of Health and Allied Professions.

Career overview

Anya completed her undergraduate degree in Neuroscience at the University of Central Lancashire and then followed on to complete her PhD in Molecular Neurobiology at the University of Nottingham, with her thesis entitled 'The molecular and cellular mechanisms of neuroinflammation in 26S Proteasome depleted neurons: a role for Astrocytes'.

Her work covered key techniques in molecular and cellular biology, leading to a specialism in histology, proteomics and the use of organotypic and acute slice models to investigate neurodegeneration.

Following this, Anya also worked for the Children Brian Tumour Centre and Action for A-T, specialising in examining pharmaceutical biomarkers and treatments, such as brain gene therapy, for paediatric illness.

Anya's current research work  focuses on creating a drug screening assay for a rare childhood neurodegenerative condition and assessing cell membrane changes in Astrocytes in neurodegenerative conditions.

Anya joined NTU in December 2023.

Research areas

Anya's research interests include:

  • Surfaceome proteomic profiling of neuroglia in neurodegenerative diseases
  • Neuroinflammation in Neurodegenerative diseases
  • The production of novel drug screening assays for paediatric neurological disorders

Publications

Snary, A.F. and Webster, C.A. (2025). Pharmacokinetics in paramedic practice. Journal of Paramedic Practice, 17(3), pp.100–105. doi:https://doi.org/10.12968/jpar.2025.0003.

Mistry, M.S., Porter, M.H., Mccrorie, D.P., Snary.A., Bailey, M.H., Coveney, D.C., Boocock, D.D., Rahman, D.R. And Layfield, P.R., 2024. Recapitulating The Post-Surgical Brain Microenvironment Of Atypical Teratoid Rhabdoid Tumours To Identify Membrane Proteins For Targeted Therapy. Neuro-Oncology, 26(Supplement_7), Pp.Vii1-Vii1.

Snary, A.F., Siam, A., Prayle, A., Suk, J.S. And Dixon, J.E., 2023,. The Development Of Non-Viral Gene Editing Strategies To Permanently Correct ATM Loss In The Brain For At Therapy. In Tissue Engineering Part A (Vol. 29, No. 13-14). 140 Huguenot Street, 3rd Fl, New Rochelle, Ny 10801 Usa: Mary Ann Liebert, In

Walugembe, C., Litchfield-Williams, M., Snary, A., Layfield, R. And Haque, F., 2023. Differential Cell Surface Proteomics Of Flotillin-1, HMBG1 And Aminopeptidase In H3 Mutated Paediatric High-Grade Glioma. Neuro-Oncology.

Suresh, S., Khan, A., Snary, A., Pickering, J., Rahman, R., Grundy, R., Layfield, R. And Haque, F., 2022.  A Comparative Proteomic Analysis Of The Cell Membrane Of Histone 3 Mutated Paediatric High-Grade Gliomas In Order To Identify Potential Immunotherapeutic Targets. Neuro-Oncology, 24(Suppl 1), P.I72.

Snary,.A., Haque, F., Pickering, M.J., Rahman, R., Grundy, R. And Layfield, R., 2022. The Identification And Validation Of Plasma Membrane Proteins As Potential Therapeutic Targets For Histone H3 Mutant Paediatric High-Grade Gliomas. Neuro-Oncology, 24(Suppl 4), P.Iv10.

Course(s) I teach on